Eske Kvanner Aasvang
Christian S. Meyhoff,
Helge Dissing Sørensen
Rigshospitalet and Bispebjerg Hospital
AND
● Type 1 diabetes (Clinically defined: insulin initiated at diabetes onset and treatment with multiple doses of insulin or continuous subcutaneous insulin infusion) (n=20)
OR
● Type 2 diabetes treated with insulin (Clinically defined: treatment with diet or oral antidiabetic drugs for at least 6 months before insulin was started) (n =20)
OR
● Type 2 diabetes treated with oral antihyperglycemic drugs and/or GLP-1 analogs (n=20)
OR
● No diabetes mellitus (excluded by an admission HbA1c <48 mmol/mol) (n=20)
A Dexcom G6 sensor measured glucose during surgery and for up to ten days afterwards. Patients and staff could not see the sensor readings and followed usual diabetes care. Researchers also recorded vital signs and 30-day complications.
Low glucose episodes lasting at least 15 minutes occurred in 43% of the 70 patients and in 70% of those with type 1 diabetes. Both low and high glucose occurred despite usual perioperative diabetes care.
– Read more